BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Diabetes mellitus
,
Hippocampus
,
Holistic medicine
,
Clofibrate
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Alfuzosin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
ADRA1A
MMP14
CD69
PIP5K1A
ZEB2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
GSE17721_POLYIC_VS_CPG_16H_BMDC_UP
GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN
REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
MCLACHLAN_DENTAL_CARIES_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Development of green differential pulse voltammetric strategy for the determination of alfuzosin hyd…
Alfuzosin ameliorates diabetes by boosting PGK1 activity in diabetic mice.
A novel HPLC-DAD method for simultaneous determination of alfuzosin and solifenacin along with their…
A sensing platform of molecular imprinted polymer-based polyaniline/carbon paste electrodes for simu…
The use of alfuzosin in the treatment of patients with acute urinary retention].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Use of Alfuzosin in Stone Treatment With ESWL
Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female
ALF-ONE : ALFuzosin ONcE Daily
Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology
Once Daily Given Alfuzosin in the Treatment of BPH
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ